Benzeno Sharon
Officer at ADPT
- Sold, on record
- $29.7M
- Dollars the filings state
- Form 4 sales
- 33
- Latest Jun 29, 2026
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ADPTAdaptive Biotechnologies CorpOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ADPTRoutineNov 21, 2025 2025
Sold 606,402 shares at $16.73 ($10.1M)
Benzeno Sharon, Chief Commercial Ofc Imm Med
10b5-1 planSold 67.1% of holdings ($15.1M position)296,791 shares leftFollows a Form 144Filing
- 2 Form 144 notice ADPTNoticeDec 4, 2025 +13 days
Filed to sell 12,604 shares ($216k)
Benzeno Sharon, Officer
10b5-1 plan0.3x usual sizeFiling
- 3 Form 4 sale ADPTRoutineDec 4, 2025 same day
Sold 12,604 shares at $16.85 ($212k)
Benzeno Sharon, Chief Commercial Ofc Imm Med
10b5-1 planSold 4.1% of holdings ($5.2M position)296,791 shares left0.3x usual sizeFollows a Form 144Filing
- 4 Form 4 sale ADPTNo planMar 11, 2026 +97 days
Sold 63,103 shares at $13.17 ($831k)
Benzeno Sharon, Chief Commercial Ofc Imm Med
No 10b5-1 planSold 18.8% of holdings ($4.4M position)272,751 shares left1.4x usual sizeFiling
- 5 Form 144 notice ADPTNoticeMar 16, 2026 +5 days
Filed to sell 63,103 shares ($916k)
Benzeno Sharon, Officer
No 10b5-1 plan1.2x usual sizeFiling
- 6 Form 144 notice ADPTNoticeJun 26, 2026 +102 days
Filed to sell 12,871 shares ($261k)
Benzeno Sharon, Officer
10b5-1 plan0.2x usual sizeFiling
- 7 Form 144 notice ADPTNoticeJun 29, 2026 +3 days
Filed to sell 152,931 shares ($3.2M)
Benzeno Sharon, Officer
10b5-1 plan2.8x usual sizeFiling
- 8 Form 4 sale ADPTUnusualJun 29, 2026 same day
Sold 165,802 shares at $21.13 ($3.5M)
Benzeno Sharon, Chief Commercial Ofc Imm Med
10b5-1 planSold 42.8% of holdings ($8.2M position)221,278 shares left3.1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (40)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jun 30, 2026 | ADPT | Chief Commercial Ofc Imm Med | Form 4 sale | 165,802 | $3.5M | 42.8% | Unusual | SEC |
| Jun 29, 2026 | Jun 29, 2026 | ADPT | Officer | Form 144 notice | 152,931 | $3.2M | Notice | SEC | |
| Jun 26, 2026 | Jun 26, 2026 | ADPT | Officer | Form 144 notice | 12,871 | $261k | Notice | SEC | |
| Mar 16, 2026 | Mar 16, 2026 | ADPT | Officer | Form 144 notice | 63,103 | $916k | Notice | SEC | |
| Mar 11, 2026 | Mar 13, 2026 | ADPT | Chief Commercial Ofc Imm Med | Form 4 sale | 63,103 | $831k | 18.8% | No plan | SEC |
| Dec 4, 2025 | Dec 8, 2025 | ADPT | Chief Commercial Ofc Imm Med | Form 4 sale | 12,604 | $212k | 4.1% | Routine | SEC |
| Dec 4, 2025 | Dec 4, 2025 | ADPT | Officer | Form 144 notice | 12,604 | $216k | Notice | SEC | |
| Nov 21, 2025 | Nov 24, 2025 | ADPT | Chief Commercial Ofc Imm Med | Form 4 sale | 606,402 | $10.1M | 67.1% | Routine | SEC |
| Nov 21, 2025 | Nov 21, 2025 | ADPT | Officer | Form 144 notice | 308,837 | $5M | Notice | SEC | |
| Nov 20, 2025 | Nov 20, 2025 | ADPT | Officer | Form 144 notice | 201,993 | $3.1M | Notice | SEC | |
| Nov 19, 2025 | Nov 19, 2025 | ADPT | Officer | Form 144 notice | 95,932 | $1.3M | Notice | SEC | |
| Mar 5, 2025 | Mar 6, 2025 | ADPT | Chief Commercial Ofc Imm Med | Form 4 sale | 44,665 | $312k | 10.2% | No plan | SEC |
| Mar 5, 2024 | Mar 6, 2024 | ADPT | Chief Commercial Ofc Imm Med | Form 4 sale | 29,390 | $101k | 8.2% | No plan | SEC |
| Mar 6, 2023 | Mar 8, 2023 | ADPT | Chief Commercial Ofc Imm Med | Form 4 sale | 11,749 | $101k | 5.0% | Plan not stated | SEC |
| Mar 7, 2022 | Mar 8, 2022 | ADPT | Chief Business Development Off | Form 4 sale | 2,670 | $32k | 2.5% | Plan not stated | SEC |
| Mar 15, 2021 | Mar 17, 2021 | ADPT | Chief Business Development Off | Form 4 sale | 1,354 | $56k | 5.6% | Plan not stated | SEC |
| Mar 1, 2021 | Mar 3, 2021 | ADPT | Chief Business Development Off | Form 4 sale | 6,771 | $390k | 100.0% | Unusual | SEC |
| Feb 19, 2021 | Mar 3, 2021 | ADPT | Chief Business Development Off | Form 4 sale | 416 | $25k | 100.0% | Unusual | SEC |
| Feb 16, 2021 | Feb 17, 2021 | ADPT | Chief Business Development Off | Form 4 sale | 16,250 | $1.1M | 100.0% | Unusual | SEC |
| Feb 1, 2021 | Feb 3, 2021 | ADPT | Chief Business Development Off | Form 4 sale | 6,770 | $377k | 100.0% | Unusual | SEC |
| Jan 19, 2021 | Jan 20, 2021 | ADPT | Chief Business Development Off | Form 4 sale | 417 | $29k | 100.0% | Unusual | SEC |
| Jan 4, 2021 | Jan 6, 2021 | ADPT | Chief Business Development Off | Form 4 sale | 6,771 | $389k | 100.0% | Unusual | SEC |
| Dec 21, 2020 | Dec 23, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 417 | $25k | 100.0% | Unusual | SEC |
| Dec 1, 2020 | Dec 2, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 6,770 | $331k | 100.0% | Unusual | SEC |
| Nov 19, 2020 | Nov 23, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 416 | $20k | 100.0% | Unusual | SEC |
| Nov 2, 2020 | Nov 4, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 6,772 | $309k | 100.0% | Unusual | SEC |
| Oct 19, 2020 | Oct 20, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 417 | $21k | 100.0% | Unusual | SEC |
| Oct 1, 2020 | Oct 2, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 6,771 | $329k | 100.0% | Unusual | SEC |
| Sep 21, 2020 | Sep 23, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 417 | $19k | 100.0% | Unusual | SEC |
| Sep 1, 2020 | Sep 2, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 6,771 | $280k | 100.0% | Unusual | SEC |
| Aug 19, 2020 | Aug 19, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 416 | $17k | 100.0% | Unusual | SEC |
| Aug 4, 2020 | Aug 5, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 7,187 | $287k | 100.0% | Unusual | SEC |
| Jul 20, 2020 | Jul 21, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 417 | $17k | 100.0% | Unusual | SEC |
| Jul 1, 2020 | Jul 2, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 6,771 | $321k | 100.0% | Unusual | SEC |
| Jun 26, 2020 | Jul 1, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 417 | $20k | 100.0% | Unusual | SEC |
| Jun 26, 2020 | Jun 30, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 417 | $20k | 100.0% | Unusual | SEC |
| Jun 19, 2020 | Jun 23, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 417 | $19k | 100.0% | Unusual | SEC |
| Jun 3, 2020 | Jun 5, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 6,770 | $271k | 100.0% | Unusual | SEC |
| May 26, 2020 | May 28, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 416 | $17k | 100.0% | Unusual | SEC |
| May 19, 2020 | May 21, 2020 | ADPT | Chief Business Development Off | Form 4 sale | 246,770 | $9.9M | 100.0% | Unusual | SEC |